Alimentation Couche-Tard Announces its Results for its Third Quarter of Fiscal Year 2021
Net earnings attributable to shareholders of the Corporation ("net earnings") were $607.5 million or $0.55 per diluted share for the...
Net earnings attributable to shareholders of the Corporation ("net earnings") were $607.5 million or $0.55 per diluted share for the...
ImmunoPrecise and Genmab enter into a technology partnership targeting infectious diseaseImmunoPrecise and Litevax advance SARS-CoV-2 vaccine candidate for further pre-clinical...
MCLEAN, Va.--(BUSINESS WIRE)--Mar 17, 2021--KLDiscovery Inc. (“KLDiscovery” or the “Company”), a leading global provider of electronic discovery, information governance and...
Clinical data and program update planned for lead program zenocutuzumab (“Zeno”) in 2Q 2021Clinical update planned for MCLA-145 in 2H...
TipRanksWells Fargo: 2 Persuasive Stocks With More than 70% Upside PossibleThe analysts at Wells Fargo have been scrutinizing the market...
NEW YORK--(Enterprise WIRE)--Mar 15, 2021--Citigroup will concern its initial quarter results via push launch at approximately 8:00 AM (ET) on...
TORONTO, ON / ACCESSWIRE / March 15, 2021 / 01 Communique Laboratory Inc. (the "Company") (TSX-V:ONE)(OTCQB:OONEF) one of the first-to-market,...
- Many worth-driving milestones expected through 2021- Trappsol® Cyclo™ Niemann Choose Disorder Style C (NPC) scientific method on track to...
Well-positioned to be a long-term supplier of raw material and critical elements to the modern-day infrastructure marketNear-term catalysts expected to...
Interim Phase 1/2 results for cirmtuzumab with ibrutinib in MCL presented at ASH in December 2020 compare favorably to historical...
NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced...
NORTH HUNTINGDON, Pa.--(BUSINESS WIRE)--Mar 11, 2021--The ExOne Company (Nasdaq: XONE) (“ExOne” or the “Company”), the global leader in industrial sand...
Fourth quarter same-store sales resilient and improved 130 basis points sequentially to (19.7%)Continued to advance new strategic focus on “Traffic-Driven...
TORONTO, March 11, 2021 /PRNewswire/ - Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), announces its financial results...
- First-in-human dose-escalation study to evaluate ability of ImmTOR™ to mitigate immunogenicity of AAV capsid initiated with initial data expected...
- Continued Focus on Effective Traffic Acquisition and Operational Efficiencies Drive Highest Level of Q4 Gross Profit and Margin Since...
Full Year Net Product Sales of $93.5 Million; Full Year Pro-Forma Revenue of $119.2 Million in Line with GuidancePost Year-end...
BloombergChina Producer Costs Jump, Including to Worldwide Inflation Hazards(Bloomberg) -- China’s producer selling prices rose at the fastest speed in...